Scarica l'app Stockscreener
0.00
100.00%
-0.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SEEL Giù?
Forum
Previsione
Frazionamento azionario
Seelos Therapeutics Inc Borsa (SEEL) Ultime notizie
Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc.; Mountain Crest Acquisition Corp. V - The Manila Times
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week LowHere's Why - MSN
J&J Expands Ketamine Case With Spravato Monotherapy Indication - insights.citeline.com
SEELQ (Seelos Therapeutics) PS Ratio : (As of Jan. 06, 2025) - GuruFocus.com
Seelos Therapeutics (NASDAQ:SEEL) Stock Price Down 4.3% – Time to Sell? - Defense World
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - The Eastern Progress Online
PTC halts development of ALS drug after trial miss - The Pharma Letter
SEELQ (Seelos Therapeutics) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Seelos Therapeutics files for Chapter 11 bankruptcy By Investing.com - Investing.com Canada
Seelos Therapeutics files for Chapter 11 bankruptcy - Investing.com
SEELQ (Seelos Therapeutics) Cash Flow from Investing : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Operating Cash Flow per Share : $-234.50 (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Long-Term Debt & Capital Lease Obligation : $0.00 Mil (As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Cash Flow from Financing : $7.73 Mil (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Shares Outstanding (EOP) : 0.21 Mil (As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Enterprise Value : $10.07 Mil (As of Nov. 21, 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Free Cash Flow : $-13.27 Mil (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) EPS (Diluted) : $-475.52 (TTM As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) EV-to-Revenue : (As of Nov. 20, 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) 14-Day RSI : 23.94 (As of Nov. 20, 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
SEELQ (Seelos Therapeutics) Preferred Stock : $0.00 Mil (As of Jun. 2024) - GuruFocus.com
Seelos Announces Second Postponement of its Annual Meeting of St - GuruFocus.com
SEELQ (Seelos Therapeutics) 9-Day RSI : 19.65 (As of Nov. 21, 2024) - GuruFocus.com
Biopharm Co. Seelos Files For Ch. 11 After Nasdaq Delisting - Law360
Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock - Quantisnow
Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - GuruFocus.com
Seelos Announces Postponement of its Annual Meeting of Stockholders - GuruFocus.com
SEELOS THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Seelos Therapeutics announces the signing of a Material Transfer - GuruFocus.com
Seelos Announces Second Postponement of its Annual Meeting of Stockholders - StockTitan
Seelos Therapeutics (NASDAQ:SEEL) and Zoetis (NYSE:ZTS) Head-To-Head Contrast - Defense World
SEEL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 1.28, Reflecting a -47.76 Downturn - The Dwinnex
Seelos Therapeutics Delisted From Nasdaq, Will Transition To OTC Market - Benzinga
Seelos gets Nasdaq delisting notice - MSN
SEEL stock touches 52-week low at $2.37 amid market challenges By Investing.com - Investing.com South Africa
SEEL stock touches 52-week low at $2.37 amid market challenges - Investing.com
Seelos Therapeutics Inc (SEEL) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Financial Health Check: Examining Seelos Therapeutics Inc (SEEL)’s Key Ratios - The Dwinnex
Seelos Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Seelos Therapeutics faces Nasdaq delisting over share price - Investing.com
SEEL stock touches 52-week low at $2.77 amid market challenges By Investing.com - Investing.com South Africa
SEEL stock touches 52-week low at $2.77 amid market challenges - Investing.com Australia
Was Seelos Therapeutics Inc (SEEL)’s session last reading good? - US Post News
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected - Benzinga
Seelos Therapeutics approves reverse stock split By Investing.com - Investing.com South Africa
Seelos Therapeutics approves reverse stock split - Investing.com India
Biotech Soars On Material Transfer Agreement - MSN
10.70%
Capitalizzazione:
|
Volume (24 ore):